{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "41000557",
    "validDate": "2028-02-26 00:00:00.000",
    "issueDate": "2013-02-26 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA04100055705",
    "prodNameC": "磷酸鈉迪皮質醇",
    "prodNameE": "Dexamethasone Sodium Phosphate",
    "indicationsName": [
        "醣類代謝皮質素"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": null,
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": null,
    "medDCode": "E",
    "ingredientsDesc": [
        "Dexamethasone sodium phosphatecontains not less than 97.0 per cent and not more than the equivalent of 103.0 per cent of 9-fluoro-11β, 17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate(C22H28FNa2O8P), calculated on the anhydrous, ethanol-free substance."
    ],
    "restraintItemsCode": [
        "02",
        "40"
    ],
    "applicantName": "台灣荃新股份有限公司",
    "applicantAddr": "台北市中正區羅斯福路二段11號3樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.",
            "factoryAddr": "NO.19, XINYE 9TH STREET,WEST AREA OF TIANJIN ECONOMIC-TECHNOLOGICAL DEVELOPMENT AREA, TIANJIN 300462, CHINA",
            "factoryCompanyAddr": null,
            "countryCode": "CN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCN0606000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Dexamethasone sodium phosphatecontains not less than 97.0 per cent and not more than the equivalent of 103.0 per cent of 9-fluoro-11β, 17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate(C22H28FNa2O8P), calculated on the anhydrous, ethanol-free substance.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "5DE54FC7-8EC9-4C46-8ECD-4F909130CF11",
            "approvedDocNo": "1129010525",
            "approvedDate": "2023-09-15",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "2",
            "atcCode": "H02AB02"
        },
        {
            "isMain": "1",
            "atcCode": "A01AC02"
        },
        {
            "isMain": "2",
            "atcCode": "D07XB05"
        },
        {
            "isMain": "2",
            "atcCode": "S01BA01"
        },
        {
            "isMain": "2",
            "atcCode": "S01CB01"
        },
        {
            "isMain": "2",
            "atcCode": "R01AD03"
        },
        {
            "isMain": "2",
            "atcCode": "D07AB19"
        },
        {
            "isMain": "2",
            "atcCode": "C05AA09"
        },
        {
            "isMain": "2",
            "atcCode": "S02BA06"
        },
        {
            "isMain": "2",
            "atcCode": "D10AA03"
        },
        {
            "isMain": "2",
            "atcCode": "S03BA01"
        }
    ]
}